CILP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CILP Antibodies for investigating Cartilage Intermediate Layer Protein (CILP) in various biological processes. CILP Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CILP is a key extracellular matrix protein that plays a significant role in cartilage development and maintenance. Research has shown that CILP influences chondrocyte function and contributes to the pathogenesis of osteoarthritis and other cartilage-related disorders. Understanding CILP function is crucial for developing therapeutic strategies aimed at treating cartilage conditions. Investigating CILP expression patterns helps reveal its distribution across different tissue types. Studying CILP interactions with other proteins provides insights into cartilage biology and disease mechanisms. Examining CILP regulation enhances knowledge of cartilage homeostasis and repair processes. Santa Cruz Biotechnology monoclonal antibodies for CILP research support scientists in advancing our understanding of cartilage biology and developing new therapeutic approaches.